Navigating Imperfect Targets: Lessons & Opportunities in Radiopharmaceutical Development
8:00 am - Wednesday 25th February 2026
- Assessing the RLT landscape, providing insights into current target successes and guiding future discovery to accelerate development and patient impact
- Opportunities and challenges for RLT R&D, incl. target identification and prioritization (Understanding the rarity of “ideal” targets like PSMA and somatostatin receptors and the implications for success)
- Defining the strategic fit of RLTs, highlighting how they complement existing oncology modalities and enable precision, combination, and patient-tailored therapies
- Future Landscape: a glimpse to the future development of target selection
New Company for 2026
